Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 38 Records) |
Query Trace: Breast Neoplasms and ESR2[original query] |
---|
Comprehensive evaluation of ESR2 variation and ovarian cancer risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008 Feb 17 (2): 393-6. Leigh Pearce Celeste, Near Aimee M, Butler Johannah L, Van Den Berg David, Bretsky Philip, Conti David V, Stram Daniel O, Pike Malcolm C, Hirschhorn Joel N, Wu Anna |
Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy. Breast cancer research and treatment 2009 Jun 115 (3): 643-50. Onitilo Adedayo A, McCarty Catherine A, Wilke Russell A, Glurich Ingrid, Engel Jessica M, Flockhart David A, Nguyen Anne, Li Lang, Mi Deming, Skaar Todd C, Jin Y |
Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy. International journal of cancer. Journal international du cancer 2010 Jun 126 (12): 2935-46. Authors are not available |
Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women. Breast cancer research : BCR 2009 11 (4): R51. Crandall Carolyn J, Sehl Mary E, Crawford Sybil L, Gold Ellen B, Habel Laurel A, Butler Lesley M, Sowers Maryfran R, Greendale Gail A, Sinsheimer Janet |
Polymorphisms in the promoter region of ESR2 gene and breast cancer susceptibility. The Journal of steroid biochemistry and molecular biology 2009 Apr 114 (3-5): 207-11. Treeck Oliver, Elemenler Esma, Kriener Christina, Horn Felicitas, Springwald Anette, Hartmann Arndt, Ortmann Ol |
The protective association of high plasma enterolactone with breast cancer is reasonably robust in women with polymorphisms in the estrogen receptor alpha and beta genes. The Journal of nutrition 2009 Mar . Sonestedt E, Ivarsson MI, Harlid S, Ericson U, Gullberg B, Carlson J, Olsson H, Adlercreutz H, Wirfält E |
Haplotypes of estrogen receptor-beta and risk of non-small cell lung cancer in women. Lung cancer (Amsterdam, Netherlands) 2011 Mar 71 (3): 258-63. Paulus Jessica K, Zhou Wei, Kraft Peter, Johnson Bruce E, Lin Xihong, Christiani David |
A systematic review of the relationship between polymorphic sites in the estrogen receptor-beta (ESR2) gene and breast cancer risk. Breast cancer research and treatment 2011 Feb 126 (1): 37-45. Yu Ke-Da, Rao Nan-Yan, Chen Ao-Xiang, Fan Lei, Yang Chen, Shao Zhi-Mi |
A candidate CpG SNP approach identifies a breast cancer associated ESR1-SNP. International journal of cancer. Journal international du cancer 2011 Oct 129 (7): 1689-98. Harlid Sophia, Ivarsson Malin I L, Butt Salma, Hussain Shehnaz, Grzybowska Ewa, Eyfjörd Jorunn Erla, Lenner Per, Försti Asta, Hemminki Kari, Manjer Jonas, Dillner Joakim, Carlson Joy |
Microsatellites in the estrogen receptor (ESR1, ESR2) and androgen receptor (AR) genes and breast cancer risk in African American and Nigerian women. PloS one 2012 7 (7): 7. Zheng Y, Huo D, Zhang J, Yoshimatsu TF, Niu Q, Olopade OI |
Indications of clinical and genetic predictors for aromatase inhibitors related musculoskeletal adverse events in Chinese Han women with breast cancer. PloS one 2013 8 (7): e68798. Wang Jingxuan, Lu Kangping, Song Ying, Xie Li, Zhao Shu, Wang Yunxuan, Sun Wenzhou, Liu Lei, Zhao Hong, Tang Dabei, Ma Wenjie, Pan Bo, Xuan Qijia, Liu Hang, Zhang Qingyu |
Given breast cancer, is fat better than thin? Impact of the estrogen receptor beta gene polymorphisms. Breast cancer research and treatment 2013 Feb 137 (3): 849-62. Borgquist Signe, Hjertberg Maria, Henningson Maria, Ingvar Christian, Rose Carsten, Jernström Hele |
Estrogen receptor 2 gene polymorphism in idiopathic scoliosis. Spine 2014 Dec 39 (26): E1599-607. Kotwicki Tomasz, Janusz Piotr, Andrusiewicz Miroslaw, Chmielewska Malgorzata, Kotwicka Malgorza |
Genetic polymorphism of ESR1 rs2881766 increases breast cancer risk in Korean women. Journal of cancer research and clinical oncology 2015 Apr 141 (4): 633-45. Son Byung Ho, Kim Mi Kyung, Yun Young Mi, Kim Hee Jeong, Yu Jong Han, Ko Beom Seok, Kim Hanna, Ahn Sei Hy |
Genetic polymorphisms of ESR1, ESR2, CYP17A1, and CYP19A1 and the risk of breast cancer: a case control study from North India. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 May 35 (5): 4517-27. Chattopadhyay Shilpi, Siddiqui Sarah, Akhtar Md Salman, Najm Mohammad Zeeshan, Deo S V S, Shukla N K, Husain Syed Akht |
A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density. Breast cancer research : BCR 2015 17 (1): 110. Rudolph Anja, Fasching Peter A, Behrens Sabine, Eilber Ursula, Bolla Manjeet K, Wang Qin, Thompson Deborah, Czene Kamila, Brand Judith S, Li Jingmei, Scott Christopher, Pankratz V Shane, Brandt Kathleen, Hallberg Emily, Olson Janet E, Lee Adam, Beckmann Matthias W, Ekici Arif B, Haeberle Lothar, Maskarinec Gertraud, Le Marchand Loic, Schumacher Fredrick, Milne Roger L, Knight Julia A, Apicella Carmel, Southey Melissa C, Kapuscinski Miroslav K, Hopper John L, Andrulis Irene L, Giles Graham G, Haiman Christopher A, Khaw Kay-Tee, Luben Robert, Hall Per, Pharoah Paul D P, Couch Fergus J, Easton Douglas F, Dos-Santos-Silva Isabel, Vachon Celine, Chang-Claude Jen |
Current evidence on the relationship between rs1256049 polymorphism in estrogen receptor-ß gene and cancer risk. International journal of clinical and experimental medicine 2014 7 (12): 5031-40. Dai Zhi-Jun, Wang Bao-Feng, Ma Yun-Feng, Kang Hua-Feng, Diao Yan, Zhao Yang, Lin Shuai, Lv Ye, Wang Meng, Wang Xi-Ji |
Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnover. Breast cancer research and treatment 2015 Nov 154 (2): 263-73. Oesterreich Steffi, Henry N Lynn, Kidwell Kelley M, Van Poznak Catherine H, Skaar Todd C, Dantzer Jessica, Li Lang, Hangartner Thomas N, Peacock Munro, Nguyen Anne T, Rae James M, Desta Zeruesenay, Philips Santosh, Storniolo Anna M, Stearns Vered, Hayes Daniel F, Flockhart David |
ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer. Breast cancer research and treatment 2015 Nov . Leyland-Jones Brian, Gray Kathryn P, Abramovitz Mark, Bouzyk Mark, Young Brandon, Long Bradley, Kammler Roswitha, Dell'Orto Patrizia, Biasi Maria Olivia, Thürlimann Beat, Harvey Vernon, Neven Patrick, Arnould Laurent, Maibach Rudolf, Price Karen N, Coates Alan S, Goldhirsch Aron, Gelber Richard D, Pagani Olivia, Viale Giuseppe, Rae James M, Regan Meredith M, |
High Estrogen Receptor ß Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients-Results from a Population-Based Breast Cancer Cohort. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Nov . Elebro Karin, Borgquist Signe, Rosendahl Ann H, Markkula Andrea, Simonsson Maria, Jirström Karin, Rose Carsten, Ingvar Christian, Jernström Hele |
Pharmacogenetics and aromatase inhibitor induced side effects in breast cancer patients. Pharmacogenomics 2017 Jun . Sini Valentina, Botticelli Andrea, Lunardi Gianluigi, Gori Stefania, Marchetti Pao |
Variants of estrogen receptor alpha and beta genes modify the severity of sporadic breast cancer. Gene 2017 Jan . Rezende Luciana Montes, Marson Fernando Augusto Lima, Lima Carmen Sílvia Passos, Bertuzzo Carmen Sílv |
Differential association of ESR1 and ESR2 gene variants with the risk of breast cancer and associated features: A case-control study. Gene 2018 Feb . Ghali Rabeb M, Al-Mutawa Maryam A, Al-Ansari Abrar K, Zaied Sonia, Bhiri Hanen, Mahjoub Touhami, Almawi Wassim |
TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer. Journal of the National Cancer Institute 2019 4 111 (11): 1202-1215. Mukhopadhyay Utpal K, Oturkar Chetan C, Adams Christina, Wickramasekera Nadi, Bansal Sanjay, Medisetty Rajesh, Miller Austin, Swetzig Wendy M, Silwal-Pandit Laxmi, Børresen-Dale Anne-Lise, Creighton Chad J, Park Jun Hyoung, Konduri Santhi D, Mukhopadhyay Alka, Caradori Alexander, Omilian Angela, Bshara Wiam, Kaipparettu Benny Abraham, Das Gokul |
Functional Analysis of Promoter Variants in Genes Involved in Sex Steroid Action, DNA Repair and Cell Cycle Control. Genes 2019 Feb 10 (3): . Hamdi Yosr, Leclerc Martin, Dumont Martine, Dubois Stéphane, Tranchant Martine, Reimnitz Guy, Soucy Penny, Cassart Pauline, Ouimet Manon, Sinnett Daniel, Chaieb M'Hamed Lajmi Lakhal, Simard Jacqu |
Immune gene expression profiling reveals heterogeneity in luminal breast tumors. Breast cancer research : BCR 2019 12 21 (1): 147. Zhu Bin, Tse Lap Ah, Wang Difei, Koka Hela, Zhang Tongwu, Abubakar Mustapha, Lee Priscilla, Wang Feng, Wu Cherry, Tsang Koon Ho, Chan Wing-Cheong, Law Sze Hong, Li Mengjie, Li Wentao, Wu Suyang, Liu Zhiguang, Huang Bixia, Zhang Han, Tang Eric, Kan Zhengyan, Lee Soohyeon, Park Yeon Hee, Nam Seok Jin, Wang Mingyi, Sun Xuezheng, Jones Kristine, Zhu Bin, Hutchinson Amy, Hicks Belynda, Prokunina-Olsson Ludmila, Shi Jianxin, Garcia-Closas Montserrat, Chanock Stephen, Yang Xiaohong |
Genetic polymorphisms of estrogen receptor genes are associated with breast cancer susceptibility in Chinese women. Cancer cell international 2019 19 11. Dai Zhijun, Tian Tian, Wang Meng, Yang Tielin, Li Hongtao, Lin Shuai, Hao Qian, Xu Peng, Deng Yujiao, Zhou Linghui, Li Na, Diao Y |
Association between ESR1, ESR2, HER2, UGT1A4, and UGT2B7 polymorphisms and breast Cancer in Jordan: a case-control study. BMC cancer 2019 Dec 19 (1): 1257. Al-Eitan Laith N, Rababa'h Doaa M, Alghamdi Mansour A, Khasawneh Rame |
ESR2 gene variants (rs1256049, rs4986938, and rs1256030) and their association with breast cancer risk. PeerJ 2022 5 10 e13379. Gallegos-Arreola Martha Patricia, Zúñiga-González Guillermo M, Figuera Luis E, Puebla-Pérez Ana María, Márquez-Rosales María Guadalupe, Gómez-Meda Belinda Claudia, Rosales-Reynoso Mónica Alejand |
Unique ESR1 and ESR2 estrogen receptor gene variants associated with altered risk of triple-negative breast cancer: A case-control study. Gene 2022 Oct 851 146969. Sghaier Ikram, Zidi Sabrina, El-Ghali Rabeb M, Daldoul Amira, Aimagambetova Gulzhanat, Almawi Wassim |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: